Purchase Order 36C24719P0078
- Not listed
- This federal contract award for $356,852.35 was issued by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The award is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract between the VA and Cardinal Health for the supply of various radiopharmaceuticals used in nuclear medicine, oncology, and diagnostic imaging services. The contract has a period of performance through September 30, 2024 and is structured as a...
- This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract, valued at $465,000.60, was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 8 to provide radiopharmaceuticals. The contract is a firm fixed price delivery order with no set-aside designation. Cardinal Health 414 has held several indefinite delivery contracts to supply...
- This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract, with a ceiling value of $517,056.85, is for the supply of radiopharmaceuticals to the VA's Veterans Integrated Service Network 8. This is a firm fixed-price purchase order contract, with an ultimate completion date of November 14, 2017. The contract is not set aside for any specific business type. Cardinal Health 414 is an established...
- This federal contract award, valued at $96,025.02, was issued by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, including medical isotopes and radiopharmaceutical products, to support nuclear medicine, oncology, and diagnostic imaging services at VA medical facilities. This is an Indefinite Delivery Vehicle (IDV) contract, which allows the VA to...
- This federal contract award is for the supply of radiopharmaceuticals to the Department of Veterans Affairs (VA). The prime contractor, Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., was awarded a $1,869,913.30 delivery order contract to provide radiopharmaceutical products to the VA's Veterans Integrated Service Network 17. The contract is a firm-fixed-price, unrestricted award with a period of performance through January 26, 2026. Cardinal Health 414, LLC is a prominent...
- This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract, valued at $94,333.31, is for the provision of radiopharmaceuticals to the Department of Veterans Affairs (VA). The contract is a Delivery Order under a larger Indefinite Delivery Vehicle (IDV) contract, with a period of performance ending on October 31, 2019. Cardinal Health 414 is a for-profit limited liability company that specializes in...
- This federal contract award is for the delivery of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The contract, valued at $141,660.89, was awarded to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and other specialized pharmaceutical products to the VA, Department of Defense (DOD), and National Institutes of Health (NIH). The contract is a...
- This is a federal contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 10 to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract, with a ceiling value of $136,204.78, is for the provision of radiopharmaceutical doses to the VA for the months of April and May 2016. The contract is a firm fixed-price purchase order with no set-aside designation. Cardinal Health 414 is an established supplier of...
- This federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., is for the delivery of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The one-year contract, awarded on October 1, 2019, has a potential value of $200,531.41 and is a firm fixed price delivery order. The contract does not have a set-aside designation. Cardinal Health 414 has provided a range of pharmaceutical products and related services,...
- This federal contract for $148,339.41 was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of emergency radiopharmaceuticals to the VA for a one-month period ending October 31, 2023. The contract is a firm fixed price purchase order with no set-aside designation. Cardinal Health 414 has extensive experience providing radiopharmaceuticals, nuclear medicine...
This federal contract award, valued at $97,959.79, was issued by the Veterans Integrated Service Network 7 (VISN 7) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, which are specialized medical products used in nuclear medicine, oncology, and diagnostic imaging services. This contract has no set-aside designation, indicating that Cardinal Health 414 is a large, established healthcare product supplier capable of meeting the VA's complex requirements for these critical medical isotopes and radiopharmaceutical products. Cardinal Health, the parent company, is a global healthcare services and products company that has a long-standing relationship with the federal government, including various contracts with the Department of Defense, VA, and National Institutes of Health for the distribution of pharmaceutical and medical supplies. The contract is a firm fixed-price purchase order with a completion date of May 20, 2020, reflecting the VA's need for a reliable and timely supply of these specialized radiopharmaceuticals to support its nuclear medicine programs and patient care.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Close Out | ($21k) | 5/20/20 | |
| P00003 | Other Administrative Action | ($13k) | 5/20/20 | |
| P00001 | Other Administrative Action | $45.8k | 2/1/19 | |
| Not listed | Not listed | $45.8k | 11/13/18 |